Showing results (71-80 of 143) with videos related to

Sort By:
Pageof 15
Journal of Clinical Pharmacology|October 11, 2003
Young and elderly type 2 diabetic patients inhaling insulin with the AERx insulin diabetes management system: a pharmacokinetic and pharmacodynamic comparisonRobert R Henry, Sunder Mudaliar, Neelima Chu, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|November 11, 2008
Response of adiponectin and its receptors to changes in metabolic state after gastric bypass surgery: dissociation between adipose tissue expression and circulating levelsMichelle K Savu, Susan A Phillips, Deborah K Oh, et al.
Diabetes Technology & Therapeutics|September 18, 2018
Effects of Dapagliflozin on 24-Hour Glycemic Control in Patients with Type 2 Diabetes: A Randomized Controlled TrialRobert R Henry, Poul Strange, Rong Zhou, et al.
The Journal of Clinical Endocrinology and Metabolism|November 6, 2008
Metabolic and hormonal changes induced by pioglitazone in polycystic ovary syndrome: a randomized, placebo-controlled clinical trialVanita R Aroda, Theodore P Ciaraldi, Paivi Burke, et al.
Clinical Diabetes : a Publication of the American Diabetes Association|February 2, 2019
A Pilot Study to Assess Clinical Utility and User Experience of Professional Continuous Glucose Monitoring Among People With Type 2 DiabetesKurt Midyett, Jeffrey R Unger, Eugene E Wright, et al.
Diabetes, Obesity & Metabolism|March 2, 2018
Effect of alirocumab on lipids and lipoproteins in individuals with metabolic syndrome without diabetes: Pooled data from 10 phase 3 trialsRobert R Henry, Dirk Müller-Wieland, Pam R Taub, et al.
Diabetes Care|February 16, 2013
Canagliflozin lowers postprandial glucose and insulin by delaying intestinal glucose absorption in addition to increasing urinary glucose excretion: results of a randomized, placebo-controlled studyDavid Polidori, Sue Sha, Sunder Mudaliar, et al.
American Journal of Physiology. Endocrinology and Metabolism|December 30, 2010
In vivo activation of ROCK1 by insulin is impaired in skeletal muscle of humans with type 2 diabetesKwang-Hoon Chun, Kang-Duk Choi, Dae-Ho Lee, et al.
Metabolism: Clinical and Experimental|May 22, 2003
Regulation of skeletal muscle morphology in type 2 diabetic subjects by troglitazone and metformin: relationship to glucose disposalOdile Mathieu-Costello, Alice Kong, Theodore P Ciaraldi, et al.
Plos One|September 26, 2018
Improved glycemic control with minimal systemic metformin exposure: Effects of Metformin Delayed-Release (Metformin DR) targeting the lower bowel over 16 weeks in a randomized trial in subjects with type 2 diabetesRobert R Henry, Juan P Frias, Brandon Walsh, et al.
Pageof 15